{"id":"colimycin","rwe":[],"tags":[],"phase":"phase_1","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Bullous myringitis","Fungal ear infection","Herpes simplex","Herpes zoster auricularis","Kidney disease","Myasthenia gravis","Neuromuscular block, function","Perforation of tympanic membrane","Pseudomembranous enterocolitis","Tuberculosis of ear","Viral ear infection"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"active","trials":["NCT01631968","NCT02482961","NCT03409679","NCT00235690","NCT05850871","NCT03477292","NCT02573064","NCT07512596","NCT02081560","NCT02208154","NCT06488794","NCT02288429","NCT02452047","NCT02472600","NCT01023087","NCT02894684","NCT02806141","NCT05613361","NCT06819462","NCT03460704","NCT00250133","NCT01863719","NCT07326540","NCT01292031","NCT06570850","NCT05960084","NCT02906722","NCT04764058","NCT01793012","NCT00920270","NCT00645723","NCT01537614","NCT01577862","NCT05586438","NCT07089186","NCT05922124","NCT02156323","NCT01060891","NCT01400750","NCT05685615","NCT00300560","NCT02117986","NCT06893835","NCT05833412","NCT07172932","NCT04633317","NCT03622450","NCT02619786","NCT01501968","NCT04208945"],"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"","brandName":"colimycin","companyId":"poitiers-university-hospital","ecosystem":[],"mechanism":{"target":"Melanocortin receptor 3, Melanocortin receptor 5, Epidermal growth factor receptor","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"Poitiers University Hospital","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"colimycin","indications":{"approved":[{"name":"Enterobacter Infection","diseaseId":"enterobacter-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection due to Escherichia coli","diseaseId":"infection-due-to-escherichia-coli","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Klebsiella Infections","diseaseId":"klebsiella-infections","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Mastoidectomy Cavity Infections","diseaseId":"mastoidectomy-cavity-infections","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Otitis externa","diseaseId":"otitis-externa","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pseudomonas Aeruginosa Infections","diseaseId":"pseudomonas-aeruginosa-infections","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT01631968","phase":"NA","title":"Incidence of Infection After Total Knee Arthroplasty Using an Erythromycin and Colistin Loaded Cement or a Standard Cement","status":"COMPLETED","sponsor":"Parc de Salut Mar","isPivotal":false,"enrollment":2948,"indication":"Infection After Primary Total Knee Arthroplasty","completionDate":"2012-05"},{"nctId":"NCT02482961","phase":"N/A","title":"Prospective Observational Study, Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection","status":"COMPLETED","sponsor":"DongGuk University","isPivotal":false,"enrollment":30,"indication":"Acinetobacter Infections","completionDate":"2018-04-04"},{"nctId":"NCT03409679","phase":"Phase 3","title":"A Multicenter, Open-label, Randomized, Active-controlled, Parallel Group, Pivotal Study to Investigate the Efficacy, Safety and Tolerability, and Pharmacokinetics of Murepavadin Combined With One Anti","status":"TERMINATED","sponsor":"Polyphor Ltd.","isPivotal":true,"enrollment":41,"indication":"Pneumonia","completionDate":"2019-07-17"},{"nctId":"NCT00235690","phase":"NA","title":"Pharmacokinetics and Pharmacodynamics of Intravenous Colistin- Pilot Study","status":"COMPLETED","sponsor":"University of Pittsburgh","isPivotal":false,"enrollment":10,"indication":"Bacteremia, Pseudomonas Infections","completionDate":"2015-08"},{"nctId":"NCT05850871","phase":"NA","title":"Evaluation of Ceftazidime-avibactam Plus Aztreonam in Patients Infected by MBL-producing Enterobacterales and CRISPR/Cas9-based Strategy for Curing Drug-resistant Genes","status":"UNKNOWN","sponsor":"Qianfoshan Hospital","isPivotal":false,"enrollment":427,"indication":"Carbapenem-Resistant Enterobacteriaceae Infection","completionDate":"2025-01-31"},{"nctId":"NCT03477292","phase":"NA","title":"A Study to Compare 7-days Versus 14 Days of Antibiotics Therapy for Ventilator Associated Pneumonia Due to Drug Resistant Acinetobacter Baumanii","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","isPivotal":false,"enrollment":41,"indication":"Ventilator Associated Pneumonia","completionDate":"2024-12-31"},{"nctId":"NCT02573064","phase":"N/A","title":"","status":"COMPLETED","sponsor":"Maimónides Biomedical Research Institute of Córdoba","isPivotal":false,"enrollment":113,"indication":"Acinetobacter Infections","completionDate":""},{"nctId":"NCT07512596","phase":"Phase 2","title":"Randomized, Double-blind, Parallel-controlled, Multicenter Phase II Clinical Study to Evaluate the Efficacy and Safety of Polymyxin E2 Mesylate Intravenous Infusion Combined With Nebulized Inhalation ","status":"NOT_YET_RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","isPivotal":false,"enrollment":48,"indication":"Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia","completionDate":"2027-07"},{"nctId":"NCT02081560","phase":"Phase 4","title":"Colistimethate and Colistin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy (CRRT)","status":"UNKNOWN","sponsor":"University of Zurich","isPivotal":false,"enrollment":10,"indication":"Infection","completionDate":"2015-08"},{"nctId":"NCT02208154","phase":"Phase 3","title":"RGNOSIS: Ecological Effects of Decolonisation Strategies in Intensive Care","status":"COMPLETED","sponsor":"MJM Bonten","isPivotal":true,"enrollment":8665,"indication":"ICU-ecology (Multidrug Resistant Bacteria), ICU-acquired Bacteraemia","completionDate":"2017-10-27"},{"nctId":"NCT06488794","phase":"Phase 2","title":"Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia: The COLIPED Investigation","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Fattouma Bourguiba","isPivotal":true,"enrollment":400,"indication":"Ventilator Associated Pneumonia","completionDate":"2028-12-31"},{"nctId":"NCT02288429","phase":"N/A","title":"Evaluation of Steady-state Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium in Cystic Fibrosis and Critically Ill Patients","status":"COMPLETED","sponsor":"University of Colorado, Denver","isPivotal":false,"enrollment":16,"indication":"Colistin","completionDate":"2019-06"},{"nctId":"NCT02452047","phase":"Phase 3","title":"A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Estimate the Efficacy and Safety of Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium + Imipe","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","isPivotal":true,"enrollment":50,"indication":"Bacterial Infections","completionDate":"2017-09-18"},{"nctId":"NCT02472600","phase":"Phase 2","title":"A Randomized Controlled Multicenter Trial of a Five Day Course of Oral Colistin and Neomycin Followed by Restoration of the Gut Microbiota Using Fecal Transplantation to Eradicate Intestinal Carriage ","status":"UNKNOWN","sponsor":"Stephen Harbarth","isPivotal":false,"enrollment":39,"indication":"Intestinal Colonization With Multidrug-resistant Bacteria","completionDate":"2018-03"},{"nctId":"NCT01023087","phase":"N/A","title":"The Incidence of Renal Impairment Associated With Polymyxin E Treatment and the Impact of Measuring Colistin Levels","status":"COMPLETED","sponsor":"Shaare Zedek Medical Center","isPivotal":false,"enrollment":70,"indication":"Sepsis","completionDate":"2011-01"},{"nctId":"NCT02894684","phase":"Phase 4","title":"Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis. An Randomised, Crossover Pilot Study of AZLI Plus Intravenous Colistin® Versus Standard Dual Intravenous","status":"COMPLETED","sponsor":"Liverpool Heart and Chest Hospital NHS Foundation Trust","isPivotal":false,"enrollment":16,"indication":"Cystic Fibrosis, Infection","completionDate":"2019-09"},{"nctId":"NCT02806141","phase":"Phase 3","title":"Aerosolized Plus Intravenous Colistin Compared With Intravenous Colistin for Adjunctive Treatment of Ventilator-associated Pneumonia Due to Pandrugs-resistant Acinetobacter Baumannii in the Neonates: ","status":"TERMINATED","sponsor":"Hat Yai Medical Education Center","isPivotal":true,"enrollment":204,"indication":"Pneumonia, Ventilator-Associated, Colistin Adverse Reaction","completionDate":"2017-10"},{"nctId":"NCT05613361","phase":"Phase 3","title":"The Effect of Curcumin Against Colistin-induced Nephrotoxicity","status":"UNKNOWN","sponsor":"October 6 University","isPivotal":true,"enrollment":214,"indication":"Acute Kidney Injury, Drug-Induced Nephropathy","completionDate":"2024-10-30"},{"nctId":"NCT06819462","phase":"NA","title":"Inhalaed Polymyxin E to Prevent Ventilator-associated Pneumonia: a Multicenter Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"Southeast University, China","isPivotal":false,"enrollment":434,"indication":"Ventilator-Associated Pneumonia (VAP), Inha'le'd","completionDate":"2028-06-30"},{"nctId":"NCT03460704","phase":"Phase 3","title":"Efficacy and Safety of 12 Months of Therapy With Inhaled Colistimethate Sodium in Subjects With Non-cystic Fibrosis Bronchiectasis Chronically Infected With P. Aeruginosa","status":"TERMINATED","sponsor":"Zambon SpA","isPivotal":true,"enrollment":287,"indication":"Non Cystic Fibrosis Bronchiectasis","completionDate":"2022-03-15"},{"nctId":"NCT00250133","phase":"N/A","title":"Microbiologic Effect of Selective Decontamination of the Digestive Tract With Colistin, Gentamicin and Nystatin","status":"TERMINATED","sponsor":"University of Pittsburgh","isPivotal":false,"enrollment":40,"indication":"VRE Colonization","completionDate":""},{"nctId":"NCT01863719","phase":"Phase 1","title":"A Phase 1, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of Aerosolized Colistimethate Sodium After Multiple Doses Administered Separately or in Combination With Intravenous Colist","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","isPivotal":false,"enrollment":27,"indication":"Pathogen Resistance, Pneumococcal Infection","completionDate":"2017-05-04"},{"nctId":"NCT07326540","phase":"Phase 3","title":"A Phase 3 Prospective, Randomized, Multicenter, Active-controlled Study to Evaluate the Efficacy and Safety of BV100 Plus Low-dose Polymyxin B Compared With Colistin Plus High-dose Ampicillin/Sulbacta","status":"NOT_YET_RECRUITING","sponsor":"BioVersys SAS","isPivotal":true,"enrollment":248,"indication":"Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP)","completionDate":"2028-03-30"},{"nctId":"NCT01292031","phase":"Phase 3","title":"Randomized, Open Label, Multicenter, Non-inferiority Trial to Compare Safety and Efficacy of Colistin vs. Meropenem in VAP Caused by CR-GNB","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","isPivotal":true,"enrollment":232,"indication":"Ventilator-associated Bacterial Pneumonia","completionDate":"2015-12"},{"nctId":"NCT06570850","phase":"Phase 4","title":"Efficacy of Colistin Monotherapy Versus Colistin Combined With Fosfomycin Against Carbapenem-Resistant Acinetobacter Baumannii Infections","status":"RECRUITING","sponsor":"Chiang Mai University","isPivotal":false,"enrollment":188,"indication":"Infection Due to Carbapenem Resistant Acinetobacter","completionDate":"2025-07"},{"nctId":"NCT05960084","phase":"N/A","title":"Impact of Reducing Colistin Use on Colistin Resistance in Humans and Poultry in Indonesia","status":"UNKNOWN","sponsor":"Erasmus Medical Center","isPivotal":false,"enrollment":803,"indication":"Colonization, Asymptomatic, Colistin","completionDate":"2025-06-01"},{"nctId":"NCT02906722","phase":"Phase 3","title":"Efficacy of Nebulized Versus Intravenous Colimycin for Treating Ventilator-associated Pneumonia Caused by Gram-negative Multidrug-resistant Bacteria: a Prospective, Multicenter, Randomized and Double-","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","isPivotal":true,"enrollment":7,"indication":"Ventilator-associated Pneumonia","completionDate":"2018-06-19"},{"nctId":"NCT04764058","phase":"Phase 1","title":"Efficacy and Safety of Colistin Based Antibiotic Therapy for Multidrug Resistant Gram Negative Infections in Pediatric Intensive Care Unit","status":"UNKNOWN","sponsor":"Ain Shams University","isPivotal":false,"enrollment":60,"indication":"Septicemia, Bacterial Infections","completionDate":"2021-09-01"},{"nctId":"NCT01793012","phase":"N/A","title":"Drug Monitoring of Antibiotics in Critical Care Patients","status":"COMPLETED","sponsor":"Ludwig-Maximilians - University of Munich","isPivotal":false,"enrollment":186,"indication":"ARDS, Sepsis","completionDate":"2015-01"},{"nctId":"NCT00920270","phase":"Phase 3","title":"Efficacy and Safety of Nebulized Colistin for Adjunctive Therapy of Hospital-Acquired Pneumonia Caused by Gram Negative Bacteria","status":"UNKNOWN","sponsor":"Mahidol University","isPivotal":true,"enrollment":140,"indication":"Pneumonia","completionDate":""},{"nctId":"NCT00645723","phase":"Phase 3","title":"Phase 3b Randomized Double Blind Controled Placebo Comparative Trial of Intravenous Colistin vs Intravenous Colistin Plus Nebulized Colistin in Patients With Ventilator-associated Pneumonia (VAP) Due ","status":"UNKNOWN","sponsor":"Hospitales Universitarios Virgen del Rocío","isPivotal":true,"enrollment":67,"indication":"Cross Infection, Pneumonia, Bacterial","completionDate":"2011-04"},{"nctId":"NCT01537614","phase":"Phase 1","title":"","status":"COMPLETED","sponsor":"Poitiers University Hospital","isPivotal":false,"enrollment":7,"indication":"Cystic Fibrosis","completionDate":""},{"nctId":"NCT01577862","phase":"Phase 3","title":"Randomised, Open-Label Clinical Trial on The Efficacy of Colistin Plus Rifampicin Treatment Versus Colistin Alone for Severe Infections Due to Multidrug-Resistant Acinetobacter Baumannii","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","isPivotal":true,"enrollment":210,"indication":"Infection Due to Resistant Bacteria, Pneumonia, Ventilator-Associated","completionDate":"2011-10"},{"nctId":"NCT05586438","phase":"Phase 4","title":"Pharmacokinetics of Colistin in Critically-ill Patients With Acute Kidney Injury Who Receive Sustained Low-Efficiency Dialysis","status":"COMPLETED","sponsor":"Mahidol University","isPivotal":false,"enrollment":13,"indication":"Bacterial Infections","completionDate":"2022-10-31"},{"nctId":"NCT07089186","phase":"Phase 3","title":"A Phase 3, Multicenter, Randomized, Open-label, Active-controlled, Parallel-design Clinical Study to Evaluate the Efficacy and Safety of Meropenem and Pralubactam for Injection in the Treatment of Car","status":"RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","isPivotal":true,"enrollment":80,"indication":"Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)","completionDate":"2027-04"},{"nctId":"NCT05922124","phase":"Phase 4","title":"Cefiderocol and Ampicillin-sulbactam vs. Colistin or Colistin-meropenem for Carbapenem Resistant Acinetobacter Baumannii Bacteremia or Hospital-acquired Pneumonia: Controlled Clinical Study With Histo","status":"RECRUITING","sponsor":"Rambam Health Care Campus","isPivotal":false,"enrollment":734,"indication":"Carbapenem Resistant Bacterial Infection, Acinetobacter Bacteremia","completionDate":"2026-09"},{"nctId":"NCT02156323","phase":"Phase 1","title":"A SINGLE-CENTER, OPEN-LABEL, RANDOMIZED, TWO SEQUENCE, 3-WAY CROSSOVER STUDY TO INVESTIGATE THE INTERACTION BETWEEN MULTIPLE DOSES OF COLISTIN METHANESULFONATE SODIUM (CMS) AND MULTIPLE DOSES OF RO703","status":"COMPLETED","sponsor":"Hoffmann-La Roche","isPivotal":false,"enrollment":28,"indication":"Healthy Volunteer","completionDate":"2015-03"},{"nctId":"NCT01060891","phase":"Phase 1","title":"","status":"COMPLETED","sponsor":"Poitiers University Hospital","isPivotal":false,"enrollment":200,"indication":"Gram-negative Bacteria","completionDate":""},{"nctId":"NCT01400750","phase":"Phase 4","title":"Prospective Randomized Trial Comparing Oral Ciproxin Plus Inhaled Colistin With Tobramycin for Inhalation for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis.","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","isPivotal":false,"enrollment":61,"indication":"Cystic Fibrosis","completionDate":"2011-05"},{"nctId":"NCT05685615","phase":"Phase 2","title":"A Multicenter, Open-label, Randomized, Active-controlled, Phase 2 Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Intravenous BV100 Combined with Polymyxin B Versus Best Available Ther","status":"COMPLETED","sponsor":"BioVersys AG","isPivotal":false,"enrollment":39,"indication":"Ventilator Associated Pneumonia","completionDate":"2024-12-11"},{"nctId":"NCT00300560","phase":"Phase 3","title":"Efficacy and Safety of Colistin for Therapy of Infections Caused by Extended Spectrum Beta-Lactamase(ESBL) Producing Klebsiella Pneumoniae or Escherichia Coli","status":"UNKNOWN","sponsor":"Mahidol University","isPivotal":true,"enrollment":152,"indication":"Infections","completionDate":"2006-12"},{"nctId":"NCT02117986","phase":"Phase 4","title":"Clinical and Microbiological Efficacy and Mortality of a Loading Dose of Colistin in Critical Ill Patients","status":"UNKNOWN","sponsor":"Hospital Barros Luco Trudeau","isPivotal":false,"enrollment":200,"indication":"Gram Negative Bacterial Infections","completionDate":"2018-12"},{"nctId":"NCT06893835","phase":"Phase 4","title":"Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline for Multi-Drug Resistant Gram Negative Bacteria","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beni-Suef University","isPivotal":false,"enrollment":132,"indication":"Infection in ICU","completionDate":"2025-06-30"},{"nctId":"NCT05833412","phase":"N/A","title":"Clinical Study to Improve the Quality of Care in Critically Ill Patients With Suspected Sepsis Through Early Molecular Diagnosis .","status":"UNKNOWN","sponsor":"Alejandro Rodriguez Oviedo , MD","isPivotal":false,"enrollment":120,"indication":"Sepsis, Molecular Diagnosis","completionDate":"2024-04-30"},{"nctId":"NCT07172932","phase":"N/A","title":"ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","isPivotal":false,"enrollment":314,"indication":"Bloodstream Infections, Enterobacteriaceae Infections","completionDate":"2023-01-30"},{"nctId":"NCT04633317","phase":"NA","title":"Aerosolized Colistin to Mechanical Ventilated Patients With CRGNB Pneumonia","status":"COMPLETED","sponsor":"Chang Gung University","isPivotal":false,"enrollment":60,"indication":"Pneumonia, Bacterial","completionDate":"2022-07-31"},{"nctId":"NCT03622450","phase":"Phase 2","title":"The Effect of Colistin Inhalation on the Clinical Outcome of Patients With Ventilator Associated Pneumonia","status":"COMPLETED","sponsor":"Nourhan Hassan Osama Thuraya Mohamed","isPivotal":true,"enrollment":40,"indication":"Ventilator Associated Pneumonia","completionDate":"2018-01-10"},{"nctId":"NCT02619786","phase":"Phase 3","title":"Therapy of Ventilator-associated Tracheobronchitis Caused by Gram Negative Bacteria With Nebulized Colistin","status":"UNKNOWN","sponsor":"Mahidol University","isPivotal":true,"enrollment":62,"indication":"Bronchitis","completionDate":"2017-12"},{"nctId":"NCT01501968","phase":"Phase 3","title":"Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity","status":"UNKNOWN","sponsor":"Mahidol University","isPivotal":true,"enrollment":54,"indication":"Drug Safety","completionDate":"2013-12"},{"nctId":"NCT04208945","phase":"NA","title":"The Effect of Nebulized Colistin on the Incidence of Gram Negative Bacterial Ventilator Associated Pneumonia in Intensive Care Unit Patients.","status":"UNKNOWN","sponsor":"University of Thessaly","isPivotal":false,"enrollment":152,"indication":"Pneumonia, Ventilator-associated, Gram-Negative Pneumonia","completionDate":"2021-09"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}